956 related articles for article (PubMed ID: 34609497)
1. Association of Regional White Matter Hyperintensities With Longitudinal Alzheimer-Like Pattern of Neurodegeneration in Older Adults.
Rizvi B; Lao PJ; Chesebro AG; Dworkin JD; Amarante E; Beato JM; Gutierrez J; Zahodne LB; Schupf N; Manly JJ; Mayeux R; Brickman AM
JAMA Netw Open; 2021 Oct; 4(10):e2125166. PubMed ID: 34609497
[TBL] [Abstract][Full Text] [Related]
2. Brain Aging Among Racially and Ethnically Diverse Middle-Aged and Older Adults.
Turney IC; Lao PJ; Rentería MA; Igwe KC; Berroa J; Rivera A; Benavides A; Morales CD; Rizvi B; Schupf N; Mayeux R; Manly JJ; Brickman AM
JAMA Neurol; 2023 Jan; 80(1):73-81. PubMed ID: 36374494
[TBL] [Abstract][Full Text] [Related]
3. Associations between white matter hyperintensities, lacunes, entorhinal cortex thickness, declarative memory and leisure activity in cognitively healthy older adults: A 7-year study.
Hotz I; Deschwanden PF; Mérillat S; Jäncke L
Neuroimage; 2023 Dec; 284():120461. PubMed ID: 37981203
[TBL] [Abstract][Full Text] [Related]
4. Entorhinal Perfusion Predicts Future Memory Decline, Neurodegeneration, and White Matter Hyperintensity Progression in Older Adults.
Bangen KJ; Thomas KR; Sanchez DL; Edmonds EC; Weigand AJ; Delano-Wood L; Bondi MW;
J Alzheimers Dis; 2021; 81(4):1711-1725. PubMed ID: 33967041
[TBL] [Abstract][Full Text] [Related]
5. Brain morphology in older African Americans, Caribbean Hispanics, and whites from northern Manhattan.
Brickman AM; Schupf N; Manly JJ; Luchsinger JA; Andrews H; Tang MX; Reitz C; Small SA; Mayeux R; DeCarli C; Brown TR
Arch Neurol; 2008 Aug; 65(8):1053-61. PubMed ID: 18695055
[TBL] [Abstract][Full Text] [Related]
6. The effect of white matter hyperintensities on cognition is mediated by cortical atrophy.
Rizvi B; Narkhede A; Last BS; Budge M; Tosto G; Manly JJ; Schupf N; Mayeux R; Brickman AM
Neurobiol Aging; 2018 Apr; 64():25-32. PubMed ID: 29328963
[TBL] [Abstract][Full Text] [Related]
7. Elevated Aortic Pulse Wave Velocity Relates to Longitudinal Gray and White Matter Changes.
Bown CW; Khan OA; Moore EE; Liu D; Pechman KR; Cambronero FE; Terry JG; Nair S; Davis LT; Gifford KA; Landman BA; Hohman TJ; Carr JJ; Jefferson AL
Arterioscler Thromb Vasc Biol; 2021 Dec; 41(12):3015-3024. PubMed ID: 34706559
[TBL] [Abstract][Full Text] [Related]
8. Regional cortical thinning, demyelination and iron loss in cerebral small vessel disease.
Li H; Jacob MA; Cai M; Duering M; Chamberland M; Norris DG; Kessels RPC; de Leeuw FE; Marques JP; Tuladhar AM
Brain; 2023 Nov; 146(11):4659-4673. PubMed ID: 37366338
[TBL] [Abstract][Full Text] [Related]
9. Reconsidering harbingers of dementia: progression of parietal lobe white matter hyperintensities predicts Alzheimer's disease incidence.
Brickman AM; Zahodne LB; Guzman VA; Narkhede A; Meier IB; Griffith EY; Provenzano FA; Schupf N; Manly JJ; Stern Y; Luchsinger JA; Mayeux R
Neurobiol Aging; 2015 Jan; 36(1):27-32. PubMed ID: 25155654
[TBL] [Abstract][Full Text] [Related]
10. Small vessel cerebrovascular disease is associated with cognition in prospective Alzheimer's clinical trial participants.
Morales CD; Cotton-Samuel D; Lao PJ; Chang JF; Pyne JD; Alshikho MJ; Lippert RV; Bista K; Hale C; Edwards NC; Igwe KC; Deters K; Zimmerman ME; Brickman AM
Alzheimers Res Ther; 2024 Feb; 16(1):25. PubMed ID: 38308344
[TBL] [Abstract][Full Text] [Related]
11. Etiology of White Matter Hyperintensities in Autosomal Dominant and Sporadic Alzheimer Disease.
Shirzadi Z; Schultz SA; Yau WW; Joseph-Mathurin N; Fitzpatrick CD; Levin R; Kantarci K; Preboske GM; Jack CR; Farlow MR; Hassenstab J; Jucker M; Morris JC; Xiong C; Karch CM; Levey AI; Gordon BA; Schofield PR; Salloway SP; Perrin RJ; McDade E; Levin J; Cruchaga C; Allegri RF; Fox NC; Goate A; Day GS; Koeppe R; Chui HC; Berman S; Mori H; Sanchez-Valle R; Lee JH; Rosa-Neto P; Ruthirakuhan M; Wu CY; Swardfager W; Benzinger TLS; Sohrabi HR; Martins RN; Bateman RJ; Johnson KA; Sperling RA; Greenberg SM; Schultz AP; Chhatwal JP;
JAMA Neurol; 2023 Dec; 80(12):1353-1363. PubMed ID: 37843849
[TBL] [Abstract][Full Text] [Related]
12. White matter hyperintensities and amyloid are independently associated with entorhinal cortex volume among individuals with mild cognitive impairment.
Guzman VA; Carmichael OT; Schwarz C; Tosto G; Zimmerman ME; Brickman AM;
Alzheimers Dement; 2013 Oct; 9(5 Suppl):S124-31. PubMed ID: 23375566
[TBL] [Abstract][Full Text] [Related]
13. Clinical and Biological Correlates of White Matter Hyperintensities in Patients With Behavioral-Variant Frontotemporal Dementia and Alzheimer Disease.
Huynh K; Piguet O; Kwok J; Dobson-Stone C; Halliday GM; Hodges JR; Landin-Romero R
Neurology; 2021 Mar; 96(13):e1743-e1754. PubMed ID: 33597290
[TBL] [Abstract][Full Text] [Related]
14. White matter hyperintensity distribution differences in aging and neurodegenerative disease cohorts.
Dadar M; Mahmoud S; Zhernovaia M; Camicioli R; Maranzano J; Duchesne S;
Neuroimage Clin; 2022; 36():103204. PubMed ID: 36155321
[TBL] [Abstract][Full Text] [Related]
15. Regional White Matter Hyperintensity Influences Grey Matter Atrophy in Mild Cognitive Impairment.
Vipin A; Foo HJL; Lim JKW; Chander RJ; Yong TT; Ng ASL; Hameed S; Ting SKS; Zhou J; Kandiah N
J Alzheimers Dis; 2018; 66(2):533-549. PubMed ID: 30320575
[TBL] [Abstract][Full Text] [Related]
16. Topographic patterns of white matter hyperintensities are associated with multimodal neuroimaging biomarkers of Alzheimer's disease.
Gaubert M; Lange C; Garnier-Crussard A; Köbe T; Bougacha S; Gonneaud J; de Flores R; Tomadesso C; Mézenge F; Landeau B; de la Sayette V; Chételat G; Wirth M
Alzheimers Res Ther; 2021 Jan; 13(1):29. PubMed ID: 33461618
[TBL] [Abstract][Full Text] [Related]
17. The effect of white matter hyperintensities on neurodegeneration in mild cognitive impairment.
Tosto G; Zimmerman ME; Hamilton JL; Carmichael OT; Brickman AM;
Alzheimers Dement; 2015 Dec; 11(12):1510-1519. PubMed ID: 26079417
[TBL] [Abstract][Full Text] [Related]
18. Carotid Intima-Media Thickness Is Associated With White Matter Hyperintensities: The Northern Manhattan Study.
Della-Morte D; Dong C; Markert MS; Elkind MSV; Sacco RL; Wright CB; Rundek T
Stroke; 2018 Feb; 49(2):304-311. PubMed ID: 29284725
[TBL] [Abstract][Full Text] [Related]
19. Amyloid, cerebrovascular disease, and neurodegeneration biomarkers are associated with cognitive trajectories in a racially and ethnically diverse, community-based sample.
Lao PJ; Boehme AK; Morales C; Laing KK; Chesebro A; Igwe KC; Gutierrez J; Gu Y; Stern Y; Schupf N; Manly JJ; Mayeux R; Brickman AM
Neurobiol Aging; 2022 Sep; 117():83-96. PubMed ID: 35679806
[TBL] [Abstract][Full Text] [Related]
20. Characterising the grey matter correlates of leukoaraiosis in cerebral small vessel disease.
Lambert C; Sam Narean J; Benjamin P; Zeestraten E; Barrick TR; Markus HS
Neuroimage Clin; 2015; 9():194-205. PubMed ID: 26448913
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
